Edwards SAV Heart Valve Approval Requires 160-Patient Postmarket Study
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences plans a July launch of its Carpentier-Edwards SAV supra-annular, porcine aortic heart valve